Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Transfusion|July 8, 2016
Relative impact of a patient blood management program on utilization of all three major blood componentsRajiv N Thakkar, K H Ken Lee, Paul M Ness, et al.
Frontiers in Psychiatry|October 2, 2024
The mesolimbic system and the loss of higher order network features in schizophrenia when learning without rewardElizabeth Martin, Asadur Chowdury, John Kopchick, et al.
Vaccine|December 3, 2019
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applicationsF T Cutts, E Dansereau, M J Ferrari, et al.
Science Advances|June 18, 2025
The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5Man Zhao, Dalin Zhang, Haowen Jiang, et al.
Schizophrenia Research|July 19, 2023
Learning without contingencies: A loss of synergy between memory and reward circuits in schizophreniaSazid M Hasan, Munajj S Huq, Asadur Z Chowdury, et al.
The Journal of Clinical Investigation|June 1, 2021
Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination-deficient cancer modelsManal Mehibel, Yu Xu, Caiyun G Li, et al.
Anesthesiology|September 9, 2017
Implementing a Health System-wide Patient Blood Management Program with a Clinical Community ApproachSteven M Frank, Rajiv N Thakkar, Stanley J Podlasek, et al.
Scientific Reports|July 2, 2025
Molecular docking and biological evaluation of a novel IWS1 inhibitor for the treatment of human retroperitoneal liposarcomaMarina Goryunova, Yiran He, Carson Karakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2021
Neutralization of PD-L2 is Essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian CancerYu Rebecca Miao, Kaushik N Thakkar, Jin Qian, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
The m6A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressorYiren Xiao, Kaushik N Thakkar, Hongjuan Zhao, et al.
Pageof 13